Antimicrobial Drug Resistance Handbook, Douglas L. Mayers (Ed.)
Àâòîð: Bradley John, Nelson John D. Íàçâàíèå: 2015 Nelson`s Pediatric Antimicrobial Therapy, 21st Edition ISBN: 1581109180 ISBN-13(EAN): 9781581109184 Èçäàòåëüñòâî: Eurospan Öåíà: 4290 ð. Íàëè÷èå íà ñêëàäå: Åñòü (1 øò.) Îïèñàíèå: Provides instant access to the most up to date recommendations for treatment of all infectious diseases in children. Provides commentary for each disease; drug descriptions cover all antimicrobial agents available and include complete information about dosing regimens.
Îïèñàíèå: Delivers quick, dependable answers to help you effectively treat a broad spectrum of pediatric infectious diseases. This medical reference book is your pocket-sized source for all of the evidence-based recommendations you need to provide the best possible care to your young patients.
Àâòîð: Fong I.W., Drlica Karl Íàçâàíèå: Antimicrobial Resistance and Implications for the 21st Century ISBN: 0387724176 ISBN-13(EAN): 9780387724171 Èçäàòåëüñòâî: Springer Ðåéòèíã: Öåíà: 18809 ð. Íàëè÷èå íà ñêëàäå: Åñòü ó ïîñòàâùèêà Ïîñòàâêà ïîä çàêàç.
Îïèñàíèå: Antimicrobial resistance can develop in any type of microbe (germ). Microbes can develop resistance to specific medicines. A common misconception is that a person’s body becomes resistant to specific drugs. However, it is microbes, not people that become resistant to the drugs. Drug resistance happens when microbes develop ways to survive the use of medicines meant to kill or weaken them. If a microbe is resistant to many drugs, treating the infections it causes can become difficult or even impossible. Someone with an infection that is resistant to a certain medicine can pass that resistant infection to another person. In this way, a hard-to-treat illness can be spread from person to person. In some cases, the illness can lead to serious disability or even death. This comprehensive, up-to-date volume aims to define issues and potential solutions to the challenges of antimicrobial resistance. The chapter authors are leading international experts on antimicrobial resistance among a variety of bacteria (Streptococcus pneumoniae, enteroccoci, staphylococci, gram-negative bacilli, mycobacteria species) viruses (HIV, herpesviruses), parasites (malaria, leishmaniasis) and fungi (Candida species, fusarium etc.). The chapters will explore the molecular mechanisms of drug resistance, the immunology and epidemiology of resistance strains, clinical implications and implications on research and lack thereof, and prevention and future directions. This volume will also describe the steps that researchers are taking to develop molecular methods for detecting resistance; develop drugs and other means to deal with newly-resistant organisms. A special chapter to address the issues on strategies to limit antimicrobial resistance propagation will be included in this volume.
Àâòîð: White G. David, Maslin-Prothero Sian, Burn Andrew, Íàçâàíèå: Frontiers in Antimicrobial Resistance ISBN: 1555813291 ISBN-13(EAN): 9781555813291 Èçäàòåëüñòâî: Wiley Ðåéòèíã: Öåíà: 9298 ð. Íàëè÷èå íà ñêëàäå: Ïîñòàâêà ïîä çàêàç.
Îïèñàíèå: Offers an examination of the state of antimicrobial and anticancer drug resistance. This volume is a tribute to Dr Levy and acknowledges his significant contributions to the field. It is a resource for infectious disease specialists, medical practitioners, and students, interested in a review of the accumulated research on resistance.
Îïèñàíèå: Aims to encourage good prescribing habits in doctors throughout the world, by describing the basic properties of antibiotics and other antimicrobial agents, and discussing the principles underlying the rational use of antimicrobial agents in the management of infection.
Îïèñàíèå: This is the inaugural volume in a new series of reviews. Each annual volume will contain authoritative reviews of developing research topics in antimicrobial therapeutics. Authors will describe how the research being reviewed can be applied to real?
Îïèñàíèå: Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased risk of cross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continued effective prescribing of licensed agents. Public awareness and concerns about drug resistant organisms has led to widespread publicity and political action in the UK, Europe and worldwide. The control of drug resistance and the implementation of good prescribing practice are now legal requirements in the UK as a result of the UK Health Act (2008). These fundamental changes underscore the ne
Îïèñàíèå: This publication provides a state-of-the-art overview of key issues related to antimicrobial resistance, including a focus on key pathogens causing common healthcare-associated and community-acquired infections. The epidemiology and therapeutic considerations of these antimicrobial resistant organisms are discussed, as well as the clinical and health economic impact of infections caused by them. This progressive reference also provides a dedicated section covering the clinical programmatic strategies used to minimize the growing antimicrobial resistance problem, including practical information related to interventional concepts and their implementation. In addition to antimicrobial resistance in the context of traditionally discussed problematic bacterial pathogens, emerging data related to clinically important fungal pathogens and Clostridium difficile are also covered.
Àâòîð: Li Íàçâàíèå: Efflux-Mediated Antimicrobial Resistance in Bacteria ISBN: 3319396560 ISBN-13(EAN): 9783319396569 Èçäàòåëüñòâî: Springer Ðåéòèíã: Öåíà: 27588 ð. Íàëè÷èå íà ñêëàäå: Åñòü ó ïîñòàâùèêà Ïîñòàâêà ïîä çàêàç.
Îïèñàíèå: This book, written by leading international experts, provides a comprehensive, current examination of transport-mediated antimicrobial resistance. As a particularly powerful mechanism of multidrug resistance, an in-depth examination of efflux pumps is conducted with bacteria of major public health concern including Enterobacteriaceae, Acinetobacter, Neisseria, Pseudomonas, staphylococci, and mycobacteria. The content spans structural biochemistry and transport mechanisms of the major transporter families and considers individual drug efflux systems across various Gram-positive and Gram-negative species. Genomic analysis of efflux pump distribution and their contribution to clinically-relevant resistance are a major focus of the text. Moreover, interplay between drug efflux pumps and other key resistance mechanisms such as intrinsic drug impermeability, inactivation, and target alterations are discussed, as well as their molecular expression-based regulation and physiological functions beyond resistance, involving biofilms, stress response, and pathogenicity. Finally, strategies are addressed to target this drug resistance mechanism with novel antimicrobials or drug inhibitor adjuvants.
Îïèñàíèå: This stimulating new edition of the well-respected title Biochemistry and Molecular Biology of Antimicrobial Drug Action primarily covers medically important antimicrobial agents, but also includes some compounds not in current medical use, which have been invaluable as research tools in biochemistry.Since the previous edition of this book, the impact of molecular biology on our understanding of the mechanisms of antimicrobial action and drug resistance has evolved significantly. This is reflected in the book’s coverage, with new material dealing with the remarkable recent developments in unraveling the complex molecular details of drug interactions with such key targets as ribosomes and the enzymes of nucleic acid replication and microbial cell wall biosynthesis. The new addition also reviews key advances in the biochemistry and molecular biology of drug-resistant pathogens including viruses, parasitic protozoa, fungi, and the much feared ‘superbugs’ such as MRSA.Completely updated and rewritten, Biochemistry and Molecular Biology of Antimicrobial Drug Action will be of great use to medical and biological sciences students taking courses in pharmacology, molecular biology, microbiology, biochemistry and chemotherapeutics. Because of the wealth of information within the covers of this important book, all those involved in research into drug action and development, whether in the pharmaceutical industry or academia, will find Biochemistry and Molecular Biology of Antimicrobial Drug Action invaluable. It should also be on the shelves of all libraries, in university medical schools and departments of biological sciences, biochemistry, and pharmacology.
Àâòîð: Jeffrey K. Aronson Íàçâàíèå: Meyler`s Side Effects of Antimicrobial Drugs, ISBN: 0444532722 ISBN-13(EAN): 9780444532725 Èçäàòåëüñòâî: Elsevier Science Ðåéòèíã: Öåíà: 5742 ð. Íàëè÷èå íà ñêëàäå: Åñòü ó ïîñòàâùèêà Ïîñòàâêà ïîä çàêàç.
Îïèñàíèå: Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician. This volume is essential for internal medicine physicians and general practitioners who prescribe antibiotic drugs, like penicillin and tetracycline that cure bacterial infections, and antiviral drugs used to treat patients with HIV and herpes viruses.
